EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Optimal Medical Therapy for Stable Ischemic Heart Disease

Brett M Montelaro, Rand Ibrahim, Marc Thames, Puja K Mehta

Medical Clinics of North America · 2024

DOI: 10.1016/j.mcna.2023.12.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Clinics of North America, 2024. Verfasst von Brett M Montelaro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, J. Willis Hurst Internal Medicine Residency Training Program, Emory University School of Medicine, At…. Hauptthemen laut MEDLINE: Myocardial Ischemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Emory University School of Medicine, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic coronary disease (CCD) is a major cause of morbidity and mortality worldwide. The most common symptom of CCD is exertional angina pectoris, a discomfort in the chest that commonly occurs during activities of daily life. Patients are dismayed by recurring episodes of angina and seek medical help in preventing or minimizing episodes. Angina occurs when the coronary arteries are unable to supply sufficient blood flow to the cardiac muscle to meet the metabolic needs of the left ventricular myocardium. While lifestyle changes and aggressive risk factor modification play a critical role in the management of CCD, management of angina usually requires pharmacologic therapy. Medications such as beta-blockers, calcium channel blockers, nitrates, ranolazine, and others ultimately work to improve the mismatch between myocardial blood flow and metabolic demand. This manuscript briefly describes the pathophysiologic basis for symptoms of angina, and how currently available anti-anginal therapies contribute to preventing or minimize the occurrence of angina.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial IschemiaHumansAngina PectorisCalcium Channel BlockersRanolazineAdrenergic beta-Antagonists

Stichwörter der Autor:innen

AnginaCoronary artery diseaseCoronary flow reserveMyocardial ischemia

Substanzen

Calcium Channel BlockersRanolazineAdrenergic beta-Antagonists

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, J. Willis Hurst Internal Medicine Residency Training Program, Emory University School of Medicine, Atlanta, GA, USA.
  • Division of Cardiology, Department of Medicine, Emory University Division of Cardiology, Atlanta, GA, USA.
  • Division of Cardiology, Department of Medicine, Emory University Division of Cardiology, Atlanta, GA, USA; Women's Translational Cardiovascular Research, Emory Women's Heart Center, Emory Clinical Cardiovascular Researc…

Förderung

  • Emory University School of Medicine
  • National Institutes of Health

Zitieren

APA

Montelaro, B. M., Ibrahim, R., Thames, M., & Mehta, P. K. (2024). Optimal Medical Therapy for Stable Ischemic Heart Disease. Medical Clinics of North America. https://doi.org/10.1016/j.mcna.2023.12.006

Vancouver

Montelaro BM, Ibrahim R, Thames M, Mehta PK. Optimal Medical Therapy for Stable Ischemic Heart Disease. Medical Clinics of North America. 2024. doi:10.1016/j.mcna.2023.12.006

BibTeX
@article{Montelaro2024,
  author = {Montelaro, Brett M and Ibrahim, Rand and Thames, Marc and Mehta, Puja K},
  title = {Optimal Medical Therapy for Stable Ischemic Heart Disease},
  journal = {Medical Clinics of North America},
  year = {2024},
  doi = {10.1016/j.mcna.2023.12.006}
}
Kostenlos starten →